Daniel R. Schimmel, MD, explains how balloon pulmonary angioplasty (BPA) uses balloons and specialized catheters to open narrowed vessels in the lungs to improve circulation and reduce symptoms…
Nick Norwitz interviews Aseem Malhotra, MD, a consultant cardiologist, on controversial new findings challenging LDL cholesterol’s role as an independent risk factor for heart disease. They discuss data…
NEW YORK (Reuters Health) – The safety and efficacy of intensive statin therapy initiated soon after a first MI are maintained at 5 years, Scandinavian investigators report. They…
NEW YORK (Reuters Health) – A lower INR for low-risk anticoagulated patients with mechanical aortic valve replacement reduces the risk of bleeding without increasing the rate of thromboembolic…
NEW YORK (Reuters Health) – Prospective study results suggest that saquinavir is the only older protease inhibitor (PI) not associated with an increased risk of myocardial infarction (MI).…
NEW YORK (Reuters Health) – Decreases in hemoglobin after transradial percutaneous coronary intervention (PCI) are minor in most patients, researchers from Quebec Heart-Lung Institute report in the July…
NEW YORK (Reuters Health) – Cardiologists should perform percutaneous coronary intervention (PCI) as soon as possible if initial treatment for ST-segment elevation myocardial infarction (STEMI) is thrombolysis, researchers…
NEW YORK (Reuters Health) The earlier a patient with ST-segment elevation myocardial infarction (STEMI) receives clopidogrel before primary coronary intervention (PCI), the better, according to a study in…
NEW YORK (Reuters Health) Central venous oxygen saturation (ScvO2) can’t be reliably estimated via catheters inserted through the femoral vein, researchers report in the July issue of Chest…
NEW YORK (Reuters Health) – Outcomes are better for patients with total coronary artery occlusions when percutaneous coronary intervention is performed with sirolimus-eluting stents rather than with bare…
NEW YORK (Reuters Health) – Eptifibatide and tirofiban are effective alternatives to abciximab given during primary percutaneous intervention for ST-elevation MI, according to the results of a meta-analysis…
NEW YORK (Reuters Health) – Patients with non-small-cell lung cancer who have not had a recurrence for 5 years after resection may not yet be free and clear.…
